- Home
- PCYO vs NKTR Comparison
PCYO vs NKTR Comparison
Compare PCYO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- NKTR
- Stock Information
- Founded
- PCYO 1976
- NKTR 1990
- Country
- PCYO United States
- NKTR United States
- Employees
- PCYO N/A
- NKTR N/A
- Industry
- PCYO Water Supply
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- PCYO Utilities
- NKTR Health Care
- Exchange
- PCYO Nasdaq
- NKTR Nasdaq
- Market Cap
- PCYO 248.0M
- NKTR 108.3M
- IPO Year
- PCYO N/A
- NKTR 1994
- Fundamental
- Price
- PCYO $10.05
- NKTR $24.25
- Analyst Decision
- PCYO
- NKTR Strong Buy
- Analyst Count
- PCYO 0
- NKTR 6
- Target Price
- PCYO N/A
- NKTR $81.67
- AVG Volume (30 Days)
- PCYO 44.6K
- NKTR 4.8M
- Earning Date
- PCYO 07-09-2025
- NKTR 08-07-2025
- Dividend Yield
- PCYO N/A
- NKTR N/A
- EPS Growth
- PCYO 123.89
- NKTR N/A
- EPS
- PCYO 0.56
- NKTR N/A
- Revenue
- PCYO $27,447,000.00
- NKTR $87,248,000.00
- Revenue This Year
- PCYO N/A
- NKTR N/A
- Revenue Next Year
- PCYO N/A
- NKTR N/A
- P/E Ratio
- PCYO $18.57
- NKTR N/A
- Revenue Growth
- PCYO 40.36
- NKTR N/A
- 52 Week Low
- PCYO $9.17
- NKTR $6.48
- 52 Week High
- PCYO $14.63
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- PCYO 39.64
- NKTR 63.40
- Support Level
- PCYO $10.39
- NKTR $21.87
- Resistance Level
- PCYO $10.96
- NKTR $26.59
- Average True Range (ATR)
- PCYO 0.34
- NKTR 4.14
- MACD
- PCYO -0.04
- NKTR 0.01
- Stochastic Oscillator
- PCYO 1.77
- NKTR 54.77
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.